Keppra Pediatric Epilepsy Claim Clears FDA Under Priority Review
Indication provides for add-on treatment of children ages four years and up with partial onset epileptic seizures. Firm expects sales force expansion to be completed by year-end.
Indication provides for add-on treatment of children ages four years and up with partial onset epileptic seizures. Firm expects sales force expansion to be completed by year-end.